Why Your Cardiologist May Prescribe Semaglutide (Wegovy)
Yale Medicine experts discuss the latest news on how semaglutide (Wegovy), an anti-obesity medication, could help lower cardiac risk.
Yale Medicine experts discuss the latest news on how semaglutide (Wegovy), an anti-obesity medication, could help lower cardiac risk.
Edited by Jonathon A. Leipsic Dr, Natalia Pinilla-Echeverri
Music, tour dates, videos and more from Young the Giant.
Objectives Although controversial, recent data suggest nighttime versus daytime laparoscopic cholecystectomy (LC) have comparable outcomes. Laparoscopic common bile duct exploration (LCBDE) for choledocholithiasis decreases length…
Mayo Clinic researchers have developed a new scoring tool that links Alzheimer’s disease subtypes with age of onset and the […]
Ischemic heart disease (IHD) is the leading cause of morbidity and mortality in both genders; however, young women fare the worst, likely reflecting the more…
Interventionalists say it’s now time to make a dent in the complication rate, whether by strict protocols or smaller devices.
Going forward, data from these kinds of studies could increasingly be used by AI to help personalize therapy for HF patients, an editorial suggests.
Left Ventricular Assist Devices buy precious time for patients on heart transplant waiting lists.
AbstractBackground and Aims. APOC3, ANGPTL3, and ANGPTL4 are circulating proteins that are actively pursued as pharmacological targets to treat dyslipidemi
The Onion brings you all of the latest news, stories, photos, videos and more from America’s finest news source.